AXIM BIOTECHNOLOGIES, INC. Net Income (Loss) Available to Common Stockholders, Basic
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Net Income (Loss) Available to Common Stockholders, Basic of -$6.24 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2023-04-17
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-03-31 was -$2.09M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-12-31 was -$8.05M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-09-30 was -$12.67M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-06-30 was $5.56M, a 34.33% increase year-over-year.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$6.24M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for fiscal 2021 was -$16.03M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for fiscal 2020 was -$6.41M.
- AXIM BIOTECHNOLOGIES, INC. net income (loss) available to common stockholders, basic for fiscal 2019 was -$6.45M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$6.24M 10-K · filed 2023-04-17 | |||
| 2022-03-31 | -$2.09M 10-Q · filed 2022-05-23 | -$10.14M derived: sum of 2 quarters · filed 2023-04-17 | -$22.81M derived: sum of 3 quarters · filed 2023-04-17 | -$17.25M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-12-31 | -$8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$20.72M derived: sum of 2 quarters · filed 2023-04-17 | -$15.17M derived: sum of 3 quarters · filed 2023-04-17 | -$16.03M 10-K · filed 2023-04-17 |
| 2021-09-30 | -$12.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | -$7.12M derived: sum of 2 quarters · filed 2021-11-22 | -$7.98M 10-Q · filed 2021-11-22 | -$10.38M derived: sum of 4 quarters · filed 2022-05-23 |
| 2021-06-30 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $4.69M 10-Q · filed 2021-08-23 | $2.29M derived: sum of 3 quarters · filed 2022-05-23 | -$3.83M derived: sum of 4 quarters · filed 2022-05-23 |
| 2021-03-31 | -$864.54K 10-Q · filed 2022-05-23 | -$3.26M derived: sum of 2 quarters · filed 2022-05-23 | -$9.38M derived: sum of 3 quarters · filed 2022-05-23 | -$5.25M derived: sum of 4 quarters · filed 2022-05-23 |
| 2020-12-31 | -$2.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-04-19 | -$8.52M derived: sum of 2 quarters · filed 2022-04-19 | -$4.38M derived: sum of 3 quarters · filed 2022-04-19 | -$6.41M 10-K/A · filed 2022-04-19 |
| 2020-09-30 | -$6.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | -$1.98M derived: sum of 2 quarters · filed 2021-11-22 | -$4.01M 10-Q · filed 2021-11-22 | -$5.45M derived: sum of 4 quarters · filed 2021-11-22 |
| 2020-06-30 | $4.14M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-23 | $2.11M 10-Q · filed 2021-08-23 | $671.64K derived: sum of 3 quarters · filed 2021-08-23 | -$191.97K derived: sum of 4 quarters · filed 2021-08-23 |
| 2020-03-31 | -$2.03M 10-Q/A · filed 2020-07-02 | -$3.46M derived: sum of 2 quarters · filed 2021-04-26 | -$4.33M derived: sum of 3 quarters · filed 2021-04-26 | -$6.13M derived: sum of 4 quarters · filed 2021-04-26 |
| 2019-12-31 | -$1.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | -$2.30M derived: sum of 2 quarters · filed 2021-04-26 | -$4.10M derived: sum of 3 quarters · filed 2021-04-26 | -$6.45M 10-K/A · filed 2021-04-26 |
| 2019-09-30 | -$863.62K 10-Q · filed 2019-11-14 | -$2.67M derived: sum of 2 quarters · filed 2019-11-14 | -$5.01M 10-Q · filed 2019-11-14 | -$5.99M derived: sum of 4 quarters · filed 2020-07-02 |
| 2019-06-30 | -$1.81M 10-Q · filed 2019-08-14 | -$4.15M 10-Q · filed 2019-08-14 | -$5.13M derived: sum of 3 quarters · filed 2020-07-02 | -$6.46M derived: sum of 4 quarters · filed 2020-07-02 |
| 2019-03-31 | -$2.34M 10-Q/A · filed 2020-07-02 | -$3.32M derived: sum of 2 quarters · filed 2020-07-02 | -$4.66M derived: sum of 3 quarters · filed 2020-07-02 | -$6.33M derived: sum of 4 quarters · filed 2020-07-02 |
| 2018-12-31 | -$978.89K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | -$2.31M derived: sum of 2 quarters · filed 2020-05-20 | -$3.99M derived: sum of 3 quarters · filed 2020-05-20 | -$6.75M 10-K/A · filed 2020-05-20 |
| 2018-09-30 | -$1.33M 10-Q · filed 2019-11-14 | -$3.01M derived: sum of 2 quarters · filed 2019-11-14 | -$5.78M 10-Q · filed 2019-11-14 | -$7.21M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$1.68M 10-Q · filed 2019-08-14 | -$4.44M 10-Q · filed 2019-08-14 | -$5.88M derived: sum of 3 quarters · filed 2019-08-14 | -$7.52M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$2.76M 10-Q · filed 2019-05-15 | -$4.20M derived: sum of 2 quarters · filed 2019-05-15 | -$5.84M derived: sum of 3 quarters · filed 2019-05-15 | -$6.41M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-08 | -$3.08M derived: sum of 2 quarters · filed 2019-04-08 | -$3.64M derived: sum of 3 quarters · filed 2019-04-08 | -$4.17M 10-K · filed 2019-04-08 |
| 2017-09-30 | -$1.64M 10-Q · filed 2018-11-14 | -$2.21M derived: sum of 2 quarters · filed 2018-11-14 | -$2.73M 10-Q · filed 2018-11-14 | -$3.91M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$564.74K 10-Q · filed 2018-08-17 | -$1.09M 10-Q · filed 2018-08-17 | -$2.27M derived: sum of 3 quarters · filed 2018-08-17 | -$5.53M derived: sum of 4 quarters · filed 2018-08-17 |
| 2017-03-31 | -$524.16K 10-Q · filed 2018-05-18 | -$1.71M derived: sum of 2 quarters · filed 2018-05-18 | -$4.97M derived: sum of 3 quarters · filed 2018-05-18 | -$6.85M derived: sum of 4 quarters · filed 2018-05-18 |
| 2016-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$4.44M derived: sum of 2 quarters · filed 2018-03-15 | -$6.33M derived: sum of 3 quarters · filed 2018-03-15 | -$7.28M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$3.26M 10-Q · filed 2017-11-20 | -$5.15M derived: sum of 2 quarters · filed 2017-11-20 | -$6.10M 10-Q · filed 2017-11-20 | |
| 2016-06-30 | -$1.89M 10-Q · filed 2017-09-14 | -$2.84M 10-Q · filed 2017-09-14 |